Tam as Karosi, MD, PhD; P eter Csomor, MSc; Istv an Sziklai, MD, DSc Objectives/Hypothesis: Biofilms might play a potential role in the pathogenesis and high recurrence rate of chronic rhinosinusitis with nasal polyposis (CRSwNP). Biofilm persistence has been thought to correlate with epithelial damage, subepithelial inflammatory cell infiltration, and tumor necrosis factor-a receptor (TNFR) expression in CRSwNP.
INTRODUCTION
Chronic rhinosinusitis (CRS) is a common inflammatory disease characterized by various symptoms (nasal obstruction, olfactory dysfunction, nasal discharge, and tension pain) that persist over 12 weeks. 1, 2 Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a separate diagnostic and therapeutic entity, although the etiopathomechanism is still uncertain. 1, 2 Several hypotheses have arisen as the explanation of the pathogenesis of CRS, which is currently considered as an immunological disease affected by multiple factors. 3, 4 These are immunological disorders, environmental factors, allergic rhinitis, bronchial asthma, aspirin intolerance, Staphylococcus superantigens, fungal infections, and the presence of different biofilms. [2] [3] [4] [5] Biofilms are the primary structures of bacterial and fungal survival and proliferation, which are characterized by a self-produced three-dimensional extracellular matrix that consists of polysaccharides, proteins, nucleic acids, and water. [5] [6] [7] Bacterial biofilms are characterized by extremely high resistance against antibiotics and host immune reactions due to the physical barrier formed by the polysaccharide matrix that blocks the diffusion of antibiotics, superoxides, immunoglobulins, and opsonins. [5] [6] [7] Biofilms might contribute to the epithelial damage and subsequent hyperplasia of the subepithelial layer infiltrated by inflammatory cells. 8 Furthermore, persisting biofilms in CRSwNP cases may be responsible for surgical failures and high recurrence rate of disease. 1, 4, 5, 7 Because biofilms are reported to play a central role in the pathogenesis of CRSwNP, a rapid, inexpensive, and reliable method was necessary for biofilm detection. 5, 9 In 2010, Hochstim et al. reported a reliable and robust method for biofilm detection that was based on conventional hematoxylin-eosin (HE) staining of fresh surgical specimens obtained from patients with CRSwNP. 10 In 2011, T oth et al. confirmed these results by the combined application of HE and Gram staining protocols. 11 Several cytokines (interleukin [IL]-1, IL-4, IL-5, IL-6, IL-8, and tumor necrosis factor-a [TNF-a]) might play important roles in the olfactory dysfunction, which is a common and debilitating symptom of patients with CRSwNP. [12] [13] [14] The epithelial damage, desensitization of odorant-induced signaling, and apoptotic loss of olfactory neurons are mainly associated with increased TNF-a production in the subepithelial layer of nasal polyps. 12, 13 Furthermore, TNF-a inhibits the regeneration of immature olfactory neurons from their progenitor cells located in the basal layer of the olfactory epithelium. 12, 13 However, the mechanism of olfactory dysfunction in CRSwNP is not completely understood. 12, 13 TNF-a can also have adverse effects on the respiratory mucosa, causing ciliated cell loss, epithelial metaplasia, and further accumulation of inflammatory cells in the subepithelial layer. 8, 14 The association between biofilm presence and proinflammatory cytokine expression, however, is not clear. 15 Biological effects of TNF-a are mediated by two different receptors. 16, 17 Type I TNF-a receptor (TNFR-I), a member of TNF superfamily I, is generally expressed by all nucleated human cells and has a broader spectrum of biological influences than type II TNF-a receptor (TNFR-II). 18, 19 TNFR-II, a member of TNF superfamily II, is exclusively expressed by lymphocytes and antigen presenting cells. 16, 18 Increased expression of TNFR-II is usually seen in acute inflammatory reaction, because it plays an important role in the recruitment of T-helper cells via induction of proinflammatory cytokine release (IL-1, IL-4, IL-5, IL-6, and TGF-b). 17, 18 Activated TNFR-I forms a homotrimer structure activating the silencer of death domains, which binds the TNFR-associated death domain, allowing three different ways of signal transduction. 20 The first and most important way is the activation of the nuclear factor kappa-light-chain-enhancer of activated B cells system providing inflammatory cell survival and proliferation. 20, 21 The second way is the activation of the mitogen-activated protein kinases (MAPK) system, which is associated with the phosphorylation of several transcription factors (c-Jun N-terminal kinase, p38-MAPK, extracellular signal-regulated kinases) leading to intense inflammatory cell proliferation. 20, 21 The third way of TNFR-I-associated signalization is the death domain-mediated and caspase-associated induction of apoptosis. 20, 22 This study investigated the presence of biofilms on the surface of nasal polyps corresponding to the subepithelial inflammatory changes and epithelial TNF-a receptor expression.
MATERIALS AND METHODS

Patients and Controls
A case-control experimental study was performed on nasal polyp specimens obtained from patients with CRSwNP who underwent endoscopic sinus surgery (ESS) in the Department of Otorhinolaryngology and Head and Neck Surgery, University of Debrecen. Nasal polyps were collected between February 2010 and July 2010. The group of 36 patients consisted of 21 men and 15 women (mean age, 46.7 years; range, 27-71 years) with the diagnosis of CRSwNP confirmed by nasal endoscopy and computed tomography (CT) scans of paranasal sinuses. The Lund-Mackay scores of coronal reconstructed CT scans varied between 9 and 24, with an average score of 20 indicating serious involvement of paranasal sinuses by CRS. The score was higher than 20 in 80% of patients (n ¼ 29). The clinical history and findings of physical examinations were obtained during confirmation of the diagnosis of CRSwNP. Clinical information on bronchial asthma, allergic rhinitis, aspirin intolerance, previous ESS, topical steroid treatment, and systemic antimicrobial therapy was recorded before surgery. Five patients (13%) had bronchial asthma, 8% (n ¼ 3) had allergic rhinitis, and 3% (n ¼ 1) had the diagnosis of aspirin intolerance. This patient had complete acetylsalicylic acid triad (aka, Samter's triad: nasal polyposis, bronchial asthma, and aspirin intolerance). 1,2 Diagnosis of allergic rhinitis was based on the clinical history, physical examination, and allergen-specific intracutaneous skin-prick test. In some cases, inhalation allergen-specific serum immunoglobulin G (IgG) levels were also measured by enzyme-linked immunosorbent assay. The diagnosis of bronchial asthma was based on the clinical history and on the respiratory functional test. The diagnosis was stated by a pulmonologist in all cases. Aspirin intolerance was based on the presence of aspirininduced hypersensitive reaction in the clinical history of the patients. Repeated ESS was performed in 22% (n ¼ 8) of patients, which is an important predictive factor for CRS recurrence. In this group, the number of previous surgeries varied between one and six, with an average ESS number of 2.3. All patients were treated by topical mometasone furoate monohydrate (Nasonex; Merck/Schering-Plough, North Wales, PA), 200 lg/day before surgery. The average period of intranasal steroid treatment was 27.3 months, which varied between 5 and 57 months. Preoperative systemic antibiotic treatment was performed in two (5%) patients due to recurring acute rhinosinusitis. Table I summarizes the clinical history of patients with  CRSwNP. All the nasal polyps collected during ESS were processed by histopathological analysis. Only nasal polyps larger than 2 cm and could be removed by a straight ESS forceps without any surface injury or iatrogenic disruption of biofilm layers were analyzed. The removal was gently performed at the roots of the nasal polyps.
Eight patients (males ¼ 7; females ¼ 1; mean age, 41.3 years; range, 22-57 years) scheduled for septoplasty for nasal obstruction without a medical history of CRS were recruited into the negative control group. Tissue specimens of approximately 0.2 cm 3 were obtained from the anterior mucosal surface of the inferior turbinate. All patients gave their informed consent before donating their tissue samples for the study. The institutional ethical committee approved our study. The study was carried out according to the Declaration of Helsinki.
HE and Gram Staining
A combination of HE and Gram staining protocols is a reliable method for the detection of biofilm presence and corresponding histopathological changes, because HE staining is for the investigation of microscopic architecture, whereas the Gram protocol stains various microbiological elements. 11 A total of 44 nasal mucosa specimens were fixed in 10% w/v formaldehyde. Specimens were embedded in 15% (w/v) purified gelatin for 24 hours at 56 C and refixed in 4% (w/v) paraformaldehyde for 24 hours at 20 C. Blocks were cryoprotected in 20% (w/v) sucrose solution for 2 hours at 4 C and sectioned into 5-lm slides at À25 C (MNT-200; Slee, Mainz, Germany). Slides were stored in 0.1 M phosphate-buffered saline (PBS) containing 0.03% (w/v) sodium azide at 4 C. Three consecutive 5-lm frozen cut sections were examined as follows: 1) conventional staining with HE, 2) conventional Gram staining, and 3) TNFR-I-and TNFR-II-specific immunofluorescent assays (IFA). Histological pretreatment protocol was performed by an independent laboratory assistant. Histological examinations were blinded for two independent researchers; one researcher analyzed the sections stained by HE and Gram (P.C.), and the other examined the results of IFA (T.K.). The criteria for the histological detection of biofilms were based on the presence of characteristic polysaccharide layer with Gram-positive or Gram-negative microcolonies. The architecture of epithelium and the subepithelial cellular infiltration were correlated to the presence or absence of biofilms and to the expression pattern of type I and II TNF-a receptors. 
TNFR-I-and TNFR-II-Specific IFA
RESULTS
Altogether, 36 patients with CRSwNP who underwent ESS were included in this study. The histopathological examination revealed inflammatory nasal polyps with eosinophilic, polymorphonuclear, and plasmacyte infiltration of the subepithelial layer in all cases. Bacterial (n ¼ 21), fungal (n ¼ 4), or combined (n ¼ 4) biofilms were detected in 29 (80.5%) of 36 patients with CRSwNP ( Fig. 1 , Table II ). In the biofilmnegative cases (n ¼ 7, 19.5%), histopathological analysis revealed ciliated columnar epithelium with predominantly eosinophilic infiltration of the subepithelial layer ( Fig. 2 , Table II ). All patients diagnosed with allergic rhinitis (n ¼ 3, 42.8%) were recruited into the biofilm negative group (n ¼ 7) (Table II) . In our series, HE staining displayed a strong correlation with the results of Gram staining and was found to be a reliable predictor of the presence or absence of biofilms. No discrepancies were found between the two staining protocols (Table II) . Disintegration or squamous cell metaplasia of the epithelial layer due to the subepithelial inflammatory reactions were strong predictors for biofilm detection (Fig. 1 , Table II ). Among biofilm-positive cases, neutrophil infiltration of the subepithelial layer was found to be the most important factor of biofilm presence (Fig. 1 , Table II ). In the biofilm-positive specimens, histopathological characteristics of the respiratory mucosa and the dominant inflammatory cell type of the subepithelial layer were strongly associated with the increased TNFR-I and II expression ( Fig. 1 ). There was no statistically significant difference between the number of TNFR-I and II expressing cells (Fig. 3) . It was found that normal respiratory mucosa with columnar ciliated epithelium is not associated with the presence of different types of biofilms (Fig. 2 , Table II ). Furthermore, predominant eosinophil infiltration of the subepithelial layer decreased the chance of biofilm detection (Fig. 2 , Table II ). According to IFA results, biofilmnegative cases were characterized by significantly decreased TNFR-I and II expression compared to biofilm-positive specimens (P < .001) ( Fig. 3) . It was shown that the average number of TNFR-II-positive epithelial cells was significantly higher than the TNFR-I expressing population (P < .05) (Fig. 3) . No biofilm-like structures were detected in mucosal specimens obtained from the inferior turbinate of patients (n ¼ 8) applied as negative controls (Fig. 4) . In negative controls, the TNFR-I and II expressing cells were significantly underrepresented in the epithelial layer of the nasal mucosa ( Fig. 4) .
DISCUSSION
In the present study, we demonstrated the presence of biofilms in 29 patients with CRSwNP by the combined application of HE and Gram protocols. Absence of biofilms was not associated with the single employment of HE or Gram staining. Furthermore, biofilm detection showed statistically significant correlation to the increased TNFR-I and II expression in the epithelial layer of nasal polyps. Although the presence of biofilm itself is supposed to be one of the most important factors in the pathogenesis of CRSwNP, microbiological identification of different bacterial and fungal species involved in biofilm formation still requires culturing or fluorescence in situ hybridization analysis with species-specific oligonucleotide probes. 5, 9, 10 There is increasing evidence that biofilms affect the intensity of subepithelial inflammatory reaction in CRSwNP. 4, 15 Plasmacytes, neutrophil and eosinophil granulocytes accumulating in the subepithelial layer of nasal polyps are responsible for the uncontrolled release of several proinflammatory cytokines. 3, 14 Increased expression of these peptides-mainly TNF-a-has serious morphological and functional consequences affecting the integrity of respiratory and olfactory mucosa. 3, 12, 13 In general, cytokines produced by T-helper cells such as IL-4 and IL-5 are overexpressed in CRSwNP. 3, 14 It has been reported that single nucleotide polymorphism (SNP) of IL-4 promoter region is associated with nasal polyps, and IL-4 appears to modify the metabolic activity of fibroblasts. 3, 23 Enterotoxin B of Staphylococcus species induces IL-5 release in the subepithelial layer, whereas IL-8 seems to be upregulated by Staphylococcus epidermidis. 3, 24, 25 Both cytokines are supposed to increase the subepithelial matrix production in nasal polyps. 3, 24 IL-1 and TNF-a being proinflammatory cytokines are upregulated in CRSwNP, which can be associated with several disease-specific SNPs previously identified. 26 B-cell activating factor has been also reported to contribute to the pathogenesis of CRSwNP via the local induction of immunoglobulin A production and activation of eosinophil granulocytes. 27 In contrast, cytokines having immunomodulator effects such as interferon-c and transforming growth factor-b are downregulated in nasal polyps. 3 In spite of the intense research, the mechanism of olfactory dysfunction and architectural changes of the nasal mucosa remains poorly understood in CRSwNP. 12, 13 TNF-a has been suggested to play a crucial role in olfactory dysfunction by the suppression of progenitor cell proliferation and olfactory regeneartion. 13 In the transgenic mouse model for CRS, electro-olfactography results implied that TNF-a directly lead to olfactory neuron dysfunction that was independent from the severity of inflammatory reactions. 13 This inflammatory process seems to be reversible, because TNF-a does not directly cause neuronal apoptosis. 12, 13 It has been reported that intranasal and oral administration of steroids (prednisolone, mometasone furoat) significantly decreases the expression levels of IL-1, Il-6 and TNF-a in nasal polyps. 14, 24 These findings also support the hypothesis that the inflammatory reactions in CRSwNP are correlated to the elevated levels of proinflammatory cytokines. 3, 14, 24 Corticosteroids have beneficial effects on the symptoms of CRSwNP and significantly decrease nasal obstruction and olfactory dysfunction. 1, 2, 14, 15 Hypothetically, steroid treatment may have adverse effects on the biofilm presence and thickness via the inhibition of local immune response. 11 As we have concluded previously, steroid and systemic antibiotic treatment might have a severe influence on the flora of nasal mucosa, and in fact these medications might affect the structure and thickness of biofilms. 11 Because our patients were all treated by topical steroids, this association seems to be strong. In contrast, 43% of biofilm-negative specimens were obtained from patients with allergic rhinitis who were regular topical-steroid users. Furthermore, allergic rhinitis is not a real risk factor for CRSwNP by the current rhinologic consensus. 1, 2 In the future, placebo-controlled, double-blinded, dynamic studies will be necessary to prove this causative relation and to resolve this conflict.
CONCLUSION
The results of this study indicate an association between biofilm presence and increased expression of TNF-a receptors in CRSwNP. According to our observations, the severity of CRSwNP is associated with increased TNF-a receptor expression and consecutive epithelial damage, which is more likely to become colonized with bacteria. Although specific treatments are not yet available to target biofilm, its detection is an important requirement, because it is strongly associated with treatment failures and persistent symptoms of CRSwNP. 1, 2, 10, 11, 28 In general, therapeutic considerations can be divided into two main groups: blockade of biofilm formation and eradication of biofilms that have already formed. 28 Furthermore, an understanding of the role of TNF-a and its receptors in biofilm-positive CRSwNP cases may suggest novel therapeutic strategies for CRSassociated symptoms in the future. Further examinations are required to clarify the etiologic role of biofilms in the pathogenesis of CRSwNP. 
